USA launches Section 232 investigation into pharmaceuticals

Impact of US custom policies on the chemical & pharmaceutical industry

Strengthening free trade, dismantling customs duties

Overview and position on antibiotic resistance

Promoting research into new antibiotics - but how?

Containing resistances: Antibiotic monitoring in veterinary medicine

‘Switzerland seems less “hungry” for competition’

Life Sciences: Switzerland must become more active

Overview and position on relations with the EU

Full association with Horizon – why EU research ties matter to CH

Full association to Horizon Europe essential

The poison and the dose – Great panic over small values?

TFA: key facts at a glance

PFAS: Key facts at a glance

Differentiated view of "risk versus hazard"